Mar­ket­ingRx roundup: Mod­er­na, Pfiz­er, J&J top phar­mas on in­no­va­tion list; Bris­tol My­ers taps IPG for me­dia

Boston Con­sult­ing Group’s an­nu­al list of most in­no­v­a­tive com­pa­nies in­cludes a hand­ful of phar­ma com­pa­nies, with Mod­er­na in the high­est spot at no. 6. Pfiz­er and John­son & John­son were the next two best fin­ish­ing phar­mas at nos. 11 and 12, re­spec­tive­ly.

BCG, which has pub­lished its an­nu­al in­no­va­tion as­sess­ments most years since 2003, says in this year’s re­port that in­no­va­tion is get­ting its due, with 79% of com­pa­nies rank­ing it among the top three pri­or­i­ties, a 15 per­cent­age point in­crease since 2009. Two-thirds al­so said they plan to in­crease spend­ing on in­no­va­tion.

Endpoints News

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters